Abstract
Our aim in this report was to describe the characteristics of the first clinical isolate of Escherichia coli (EC-PAG-733) harboring the mcr-1 gene found in Mexico. This isolate was obtained from a fecal sample from a young child with an oncological condition. We obtained the whole-genome sequence using next-generation sequencing and analyzed the sequence by bioinformatics tools. EC-PAG-733 was resistant to third- and fourth-generation cephalosporins and was susceptible to all carbapenems and amikacin; it was also resistant to ciprofloxacin, levofloxacin, gentamicin and colistin at a minimum inhibitory concentration (MIC) of 4 μg/mL. This isolate was classified as O11:H25-ST457. EC-PAG-733 harbored an ESBL type CTX-M-55 as well as several virulence factors that have been associated with Enteroaggregative Escherichia coli (EAEC). The mcr-1 gene was located within an IncI2 plasmid. The results of this whole genome shotgun project were deposited in DDBJ/ENA/GenBank under the accession number QKXE00000000.
Cite
CITATION STYLE
Merida-Vieyra, J., De Colsa- Ranero, A., Arzate-Barbosa, P., Arias- de la Garza, E., Méndez-Tenorio, A., Murcia-Garzón, J., & Aquino-Andrade, A. (2019). First clinical isolate of Escherichia coli harboring mcr-1 gene in Mexico. PLoS ONE, 14(4). https://doi.org/10.1371/journal.pone.0214648
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.